Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 14, 2011

Primary Completion Date

February 11, 2017

Study Completion Date

February 11, 2017

Conditions
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical CarcinomaStage IVB Cervical Cancer AJCC v6 and v7
Interventions
DRUG

Cisplatin

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Paclitaxel

Given IV

DRUG

Veliparib

Given PO

Trial Locations (25)

10065

Memorial Sloan Kettering Cancer Center, New York

19107

Thomas Jefferson University Hospital, Philadelphia

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

22908

University of Virginia Cancer Center, Charlottesville

23298

Virginia Commonwealth University/Massey Cancer Center, Richmond

29425

Medical University of South Carolina, Charleston

30912

Augusta University Medical Center, Augusta

39216

University of Mississippi Medical Center, Jackson

39581

Singing River Hospital, Pascagoula

43210

Ohio State University Comprehensive Cancer Center, Columbus

43214

Riverside Methodist Hospital, Columbus

44106

Case Western Reserve University, Cleveland

44109

MetroHealth Medical Center, Cleveland

44124

Hillcrest Hospital Cancer Center, Mayfield Heights

44195

Cleveland Clinic Foundation, Cleveland

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

60637

University of Chicago Comprehensive Cancer Center, Chicago

63110

Washington University School of Medicine, St Louis

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

77030

M D Anderson Cancer Center, Houston

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

02905

Women and Infants Hospital, Providence

77026-1967

Lyndon Baines Johnson General Hospital, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NRG Oncology

OTHER

lead

National Cancer Institute (NCI)

NIH